These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38492358)

  • 1. Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights.
    Abdelmaksoud NM; Al-Noshokaty TM; Abdelhamid R; Abdellatif N; Mansour A; Mohamed R; Mohamed AH; Khalil NAE; Abdelhamid SS; Mohsen A; Abdelaal H; Tawfik A; Elshaer SS
    Pathol Res Pract; 2024 Apr; 256():155237. PubMed ID: 38492358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
    Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
    Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
    Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
    BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment.
    Yarahmadi A; Shahrokhi SZ; Mostafavi-Pour Z; Azarpira N
    Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Role of TGF-β1/SMAD in Diabetic Nephropathy: Mechanisms and Research Development].
    Wang Y; Guo J; Shao B; Chen H; Lan H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1065-1073. PubMed ID: 38162063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
    Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
    Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
    Guo M; Dai Y; Jiang L; Gao J
    Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
    J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory role of miRNA and lncRNA on autophagy in diabetic nephropathy.
    Yu S; Li Y; Lu X; Han Z; Li C; Yuan X; Guo D
    Cell Signal; 2024 Jun; 118():111144. PubMed ID: 38493883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
    Kato M; Natarajan R
    Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.
    Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M
    J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-Beta as a Master Regulator of Diabetic Nephropathy.
    Wang L; Wang HL; Liu TT; Lan HY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy.
    Kato M; Natarajan R
    Semin Nephrol; 2012 May; 32(3):253-60. PubMed ID: 22835456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a TF-miRNA-mRNA Regulatory Network for Diabetic Nephropathy.
    Dong F; Zheng L; Yang G
    Arch Esp Urol; 2024 Jan; 77(1):104-112. PubMed ID: 38374020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
    Peng L; Chen Y; Shi S; Wen H
    Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.
    Ming J; Sana SRGL; Deng X
    Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
    Hu Y; Yu Y; Dong H; Jiang W
    PeerJ; 2023; 11():e15437. PubMed ID: 37250717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.